Despite the availability of effective antihypertensive therapies, global blood pressure control rates remain unacceptably low. Contributing factors, such as low treatment adherence, therapeutic ...
Patients who start their blood pressure treatment with ARB drugs continue with the same medicine to a greater extent than patients who start out with other drugs. Choosing the right drug from the ...
44.7 percent of angiotensin receptor blocker initiators were continuously persistent to original drug class at three years. (HealthDay News) — For patients with hypertension, initiating treatment with ...
Patients who start their blood pressure treatment with angiotensin receptor blocker (ARB) drugs continue with the same medicine to a greater extent than patients who start out with other drugs.
Patients who start their blood pressure treatment with ARB drugs continue with the same medicine to a greater extent than patients who start out with other drugs. Choosing the right drug from the ...
* EMA - REITERATES ITS PREVIOUS ADVICE THAT PATIENTS SHOULD CONTINUE TO USE ACE INHIBITORS OR ARBS AS ADVISED BY THEIR DOCTORS * EMA - RECENT OBSERVATIONAL STUDIES OF ACE INHIBITORS AND ARBS HAVE NOT ...
Losartan may help stop the epileptic process in certain patients with hypertension. An observational study that analyzed medical records of 2.26 million patients with hypertension found a roughly 30% ...
A judge tossed a lawsuit brought by pharmaceutical companies to block a California law requiring advance notice of big price increases; the FDA is testing all angiotensin II receptor blockers (ARBs) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results